miR-221 Is down-regulated in TMPRSS2:ERG fusion-positive prostate cancer

Aida Gordanpour1, Aleksandra Stanimirovic, Robert K Nam

  • 1Department of Laboratory Medicine and Pathobiology, University of Toronto, and Sunnybrook Research Institute, Toronto, Canada.

Anticancer Research
|March 8, 2011
PubMed

Insights

MicroRNAs (miRNAs) like miR-221 are dysregulated in many cancers. This study links down-regulated miR-221 in prostate cancer to the common TMPRSS2:ERG gene fusion.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression and are frequently dysregulated in human cancers.
  • miR-221 is upregulated in various cancers, but downregulated in prostate cancer.
  • The TMPRSS2:ERG gene fusion is a hallmark of prostate cancer, found in over 50% of patients.

Purpose of the Study:

  • To investigate the association between miR-221 expression and the TMPRSS2:ERG gene fusion in prostate cancer.
  • To determine if the common TMPRSS2:ERG fusion influences miR-221 levels in prostate tumors.

Main Methods:

  • Analysis of miRNA expression profiles in a large cohort of prostate carcinoma samples.
  • Detection of TMPRSS2:ERG fusion transcripts in the same samples.
  • Correlation analysis between miR-221 levels and the presence of the TMPRSS2:ERG fusion.

Main Results:

  • Downregulation of miR-221 was observed in prostate tumors harboring the TMPRSS2:ERG fusion transcript.
  • This association was significant across a diverse cohort of prostate cancer patients.
  • This study is the first to report a direct link between miR-221 and the ERG oncogene fusion in prostate cancer.

Conclusions:

  • miR-221 downregulation is linked to the TMPRSS2:ERG gene fusion in prostate cancer.
  • This finding provides a novel connection between miRNA dysregulation and a key genetic alteration in prostate tumorigenesis.
  • Further research may explore the functional implications of this association in prostate cancer development and progression.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...